ArticleJournal of gastrointestinal oncology2022
Multiple interventional embolizations for hemostasis in hemorrhage following advanced colorectal cancer treatment: a case report.
Article in Journal of gastrointestinal oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, the incidence of serious complications in patients with advanced colorectal cancer has been progressively increasing, and the fatality rate of secondary bleeding is the highest, while most patients cannot undergo surgical intervention due to physical weakness, while interventional embolization therapy has attracted more and more attention of clinicians because of its advantages of small trauma and quick effect. Among them, multiple cases of secondary hemorrhage of different arteries are very rare. In this case, the changes of vital signs of patients were significantly stabilized after each interventional embolization therapy. Interventional embolization therapy can be used as one of the first choices for secondary hemorrhage. Case Description: Retrospectively analyzed the clinical data of a patient with advanced colorectal cancer who successively developed 7 times of secondary hemorrhage within 10 months. The two times of hemorrhage had different degrees of hemorrhagic shock, and five times showed unexplained progressive decrease in hemoglobin. The location of each hemorrhage and the arteries invaded by the tumor were different, and the embolization materials and treatment methods used each time were not the same. The effect of interventional embolization each time could effectively stop bleeding, and the patient greatly improved the quality of life with tumor survival. The patient prolonged the survival cycle for up to 16 months from the first secondary hemorrhage. Conclusions: For patients with advanced colorectal cancer complicated with secondary hemorrhage, interventional embolization can be used to control the disease and prolong the life cycle, which is one of the preferred treatment methods in clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.